학술논문

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
Document Type
Article
Source
In Annals of Oncology August 2015 26(8):1734-1740
Subject
Language
ISSN
0923-7534